23 research outputs found
Immunotherapy of Gynaecological High-Risk Human Papilloma Virus Infection With Human Leukocyte Ultrafiltrate
Immunotherapy of Gynaecological High-Risk Human Papilloma Virus Infection With Human Leukocyte Ultrafiltrate
Objective: In this preliminary presentation the outcome of women following systemic treatment of
cervical human papilloma virus (HPV) with a leukocyte ultrafiltrate is reported
Effect of Adjuvant Imiquimod 5% Cream on Sustained Clearance of Anogenital Warts Following Laser Treatment
Objectives: Imiquimod is an immune response modifier that has demonstrated a good efficacy and relatively low
recurrencerates in comparison to other genitalwart treatment modalities. The primary objective of this open-label
study was to evaluate the effect on sustained clearance of treated lesions and the safety of patient-applied topical
imiquimod after laser therapy of external anogenital warts